NCT01873846

Brief Summary

The objective of this study is to evaluate the product performance of a new silicone hydrogel soft contact lens when worn by current soft contact lens wearers on a daily wear basis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

May 28, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 10, 2013

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
6.1 years until next milestone

Results Posted

Study results publicly available

July 24, 2019

Completed
Last Updated

July 24, 2019

Status Verified

July 1, 2019

Enrollment Period

1 month

First QC Date

May 28, 2013

Results QC Date

July 1, 2019

Last Update Submit

July 23, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Preference Question: How Would You Say These Contact Lenses Compare Overall With the Contact Lenses You Usually Use?

    Participants will respond to a survey regarding their experience wearing the Test Lens after 7 days of wear. Participants were asked to answer the following question: "How would you say these contact lenses compare overall with the contact lenses you usually use?" Prefer study lenses Prefer usual lenses About the same as usual lenses

    7 days

  • Preference Question: These Contact Lenses Deliver Exceptional Clarity and Comfort All Day Long.

    Participants will respond to a survey regarding their experience wearing the Test Lens after 7 days of wear. Participants were asked to assess the following statement with respect to their usual contact lenses: "These contact lenses deliver exceptional clarity and comfort all day long." Prefer study lenses Prefer usual lenses About the same as usual lenses

    7 days

  • Preference Question: These Contact Lenses Help Maintain Healthy, White Eyes.

    Participants will respond to a survey regarding their experience wearing the Test Lens after 7 days of wear. Participants were asked to assess the following statement with respect to their usual contact lenses: "These contact lenses help maintain healthy, white eyes." Prefer study lenses Prefer usual lenses About the same as usual lenses

    7 days

Secondary Outcomes (2)

  • Lens Performance Assessment

    2 weeks

  • Any Graded Slit Lamp Finding > 2

    2 weeks

Study Arms (1)

Silicone Hydrogel Contact Lens

EXPERIMENTAL

Contact lenses to be worn in each eye on a daily wear basis for 2 weeks. Participants will be provided with Bausch + Lomb Biotrue® multi-purpose solution and contact lens cases for daily rinsing, cleaning, disinfecting, and storing their lenses.

Device: Silicone Hydrogel Contact Lens

Interventions

Silicone Hydrogel Contact Lens

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects must be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye
  • Subjects must have clear central corneas and be free of any anterior segment disorders.
  • Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand.
  • Subjects must be myopic and require lens correction from -0.25 D to -6.00 D in each eye.
  • Subject must wear their current lenses for a minimum of 12 hours per day at least four days per week.
  • Subjects must spend at least 3 hours each workday using a computer or electronic device (ie, smartphones, tablets, eReaders).
  • Subjects must habitually wear soft contact lens.
  • Subject must have no active ocular disease or allergic conjunctivitis.
  • Subject must not be using any topical ocular medications.
  • Subjects must be bothered (occasionally or frequently) by blurriness or fluctuations in vision with their current contact lenses.
  • Subjects must habitually use a lens care product for cleaning, disinfection, and storage.

You may not qualify if:

  • Subjects who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
  • Subjects with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study.
  • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Subjects with an active ocular disease or who are using any ocular medication.
  • Subjects who are not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact lenses.
  • Subjects who are presbyopic or currently wear monovision, multifocal, or toric contact lenses.
  • Subjects with an ocular astigmatism of 1.00 D or greater in either eye.
  • Subjects with anisometropia (spherical equivalent) of 2.00 D or greater in either eye.
  • Subjects with any Grade 2 or greater finding during the slit lamp examination.
  • Subjects with corneal infiltrates, of ANY GRADE, are not eligible.
  • Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
  • Subjects with any scar or neovascularization within the central 4 mm of the cornea.
  • Subjects who are aphakic.
  • Subjects who are amblyopic.
  • Subjects who have had any corneal surgery (eg, refractive surgery).
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bausch & Lomb Incorporated

Madison, New Jersey, 07940, United States

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Robert Steffen
Organization
Bausch Health Americas, Inc

Study Officials

  • Johnson Varughese

    Valeant Pharmaceuticals

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2013

First Posted

June 10, 2013

Study Start

April 1, 2013

Primary Completion

May 1, 2013

Study Completion

July 1, 2013

Last Updated

July 24, 2019

Results First Posted

July 24, 2019

Record last verified: 2019-07

Locations